AUROBINDO PHARMA LTD.
Quaterly Results
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|
Audited / UnAudited | UnAudited | UnAudited | UnAudited | Audited |
Net Sales | 73517.8 | 72194.2 | 68505.2 | 64729.6 |
Total Expenditure | 57504.7 | 58459.8 | 56991.5 | 54707.8 |
PBIDT (Excl OI) | 16013.1 | 13734.4 | 11513.7 | 10021.8 |
Other Income | 1625.2 | 1869.8 | 1163.3 | 1349.1 |
Operating Profit | 17638.3 | 15604.2 | 12677 | 11370.9 |
Interest | 755.5 | 681.8 | 565.5 | 556 |
Exceptional Items | NA | NA | -697.5 | NA |
PBDT | 16882.8 | 14922.4 | 11414 | 10814.9 |
Depreciation | 4232.7 | 4175 | 3265.6 | 3455.7 |
Profit Before Tax | 12650.1 | 10747.4 | 8148.40 | 7359.19 |
Tax | 3224.5 | 3237 | 2423.2 | 2241.5 |
Provisions and contingencies | NA | NA | NA | NA |
Profit After Tax | 9425.6 | 7510.40 | 5725.20 | 5117.69 |
Extraordinary Items | NA | NA | NA | NA |
Prior Period Expenses | NA | NA | NA | NA |
Other Adjustments | NA | NA | NA | NA |
Net Profit | 9425.6 | 7510.40 | 5725.20 | 5117.69 |
Minority Interest | -36.8 | 52.4 | 10.4 | 3.6 |
Shares of Associates | -25.9 | 9 | -28.1 | -58.6 |
Other related items | ||||
Misc. Expenses Written off | NA | NA | NA | NA |
Consolidated Net Profit | 9362.9 | 7571.8 | 5707.5 | 5062.7 |
Equity Capital | 585.9 | 585.9 | 585.9 | 585.9 |
Face Value (IN RS) | 1 | 1 | 1 | 1 |
Reserves | NA | NA | NA | NA |
Calculated EPS | 15.98 | 12.92 | 9.74 | 8.64 |
Calculated EPS (Annualised) | 63.92 | 51.69 | 38.96 | 34.56 |
No of Public Share Holdings | 282223138 | 282223138 | 282223138 | 282223138 |
% of Public Share Holdings | 48.17 | 48.17 | 48.17 | 48.17 |
| NA | NA | NA | NA |
PBIDTM% (Excl OI) | 21.78 | 19.02 | 16.80 | 15.48 |
PBIDTM% | 23.99 | 21.61 | 18.50 | 17.56 |
PBDTM% | 22.96 | 20.66 | 16.66 | 16.70 |
PBTM% | 17.20 | 14.88 | 11.89 | 11.36 |
PATM% | 12.82 | 10.40 | 8.35 | 7.90 |
"; | Notes | Notes | Notes | Notes |